Loading...

Jeni Janci, PhD

Title(s)Research Grant Project Officer, Innovation Ventures
SchoolChancellor/EVC/FAS
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, Berkeley, Berkeley, CAPhD05/2008Molecular and Cell Biology
    Duke University, Durham, NCBS05/2000Biology

    Collapse Overview 
    Collapse Overview
    Jeni began her life science career in the start-up biotech industry before earning her Ph.D. at University of California, Berkeley in Mike Levine’s laboratory. Her thesis was focused on gene regulatory networks of heart development in the primitive chordate, Ciona intestinalis. Directly after her graduate career, she re-entered the life science industry, where at Entelos she provided Quantitative Systems Pharmacology (QSP) Modeling and Simulation services to assist Research & Development for international pharmaceutical companies and other life science applications. Through consulting projects, she applied large-scale, mechanistic systems models to make critical decisions in various stages of the drug discovery and development lifecycle. She was also one of the architects of the novel Hypertension, Renal Failure, and Heart Failure PhysioLab model. Jeni then expanded her work globally on the PhysioLab platforms via training programs and consulting services.

    Jeni is excited to help advance UCSF’s world-class research to positively impact people’s health and lives. As the newly hired Program Director, Jeni will manage the diagnostics, digital health and bio-tools tracks for the Catalyst Program.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Hallow KM, Lo A, Beh J, Rodrigo M, Ermakov S, Friedman S, de Leon H, Sarkar A, Xiong Y, Sarangapani R, Schmidt H, Webb R, Kondic AG. A model-based approach to investigating the pathophysiological mechanisms of hypertension and response to antihypertensive therapies: extending the Guyton model. Am J Physiol Regul Integr Comp Physiol. 2014 May; 306(9):R647-62. PMID: 24500431.
      View in: PubMed
    2. Ragkousi K, Beh J, Sweeney S, Starobinska E, Davidson B. A single GATA factor plays discrete, lineage specific roles in ascidian heart development. Dev Biol. 2011 Apr 01; 352(1):154-63. PMID: 21238449.
      View in: PubMed
    3. Kugler JE, Passamaneck YJ, Feldman TG, Beh J, Regnier TW, Di Gregorio A. Evolutionary conservation of vertebrate notochord genes in the ascidian Ciona intestinalis. Genesis. 2008 Nov; 46(11):697-710. PMID: 18802963.
      View in: PubMed
    4. Beh J, Shi W, Levine M, Davidson B, Christiaen L. FoxF is essential for FGF-induced migration of heart progenitor cells in the ascidian Ciona intestinalis. Development. 2007 Sep; 134(18):3297-305. PMID: 17720694.
      View in: PubMed
    5. Davidson B, Shi W, Beh J, Christiaen L, Levine M. FGF signaling delineates the cardiac progenitor field in the simple chordate, Ciona intestinalis. Genes Dev. 2006 Oct 01; 20(19):2728-38. PMID: 17015434.
      View in: PubMed